STAAR Surgical (NASDAQ:STAA) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, February 28th. Analysts expect the company to announce earnings of $0.03 per share for the quarter.
Shares of STAAR Surgical (NASDAQ STAA) opened at $15.55 on Monday. The company has a quick ratio of 1.72, a current ratio of 2.24 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $640.10, a PE ratio of -311.00 and a beta of 1.25. STAAR Surgical has a fifty-two week low of $8.95 and a fifty-two week high of $17.60.
A number of brokerages have recently issued reports on STAA. BidaskClub upgraded STAAR Surgical from a “strong sell” rating to a “sell” rating in a report on Tuesday, January 16th. Benchmark reiterated a “buy” rating and set a $21.00 target price on shares of STAAR Surgical in a report on Monday, November 20th. Finally, Canaccord Genuity boosted their target price on STAAR Surgical from $17.50 to $20.00 and gave the stock a “buy” rating in a report on Friday, November 17th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $17.67.
STAAR Surgical Company Profile
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.